Cita APA

Gambardella, V., Accordino, M., Bedard, P., Cervantes, A., Hamilton, E., Italiano, A., . . . Jhaveri, K. (2025). Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374).

Citación estilo Chicago

Gambardella, V., et al. Safety Overview and Management of Inavolisib Alone and in Combination Therapies in PIK3CA-mutated, HR-positive, HER2-negative Advanced Breast Cancer (GO39374). 2025.

Cita MLA

Gambardella, V., et al. Safety Overview and Management of Inavolisib Alone and in Combination Therapies in PIK3CA-mutated, HR-positive, HER2-negative Advanced Breast Cancer (GO39374). 2025.